Literature DB >> 8005393

Inhibition of apoptosis as a mechanism of tumor promotion.

S C Wright1, J Zhong, J W Larrick.   

Abstract

Recent evidence supports the concept that tumor growth in vivo depends on evasion of normal homeostatic control mechanisms that operate through induction of cell death by apoptosis. This study tested the hypothesis that a common property shared by known or suspected tumor promoters is the ability to block the process of apoptosis. A total of 10 tumor promoters were tested and all were found to inhibit DNA fragmentation and cell death of 7 different cell lines triggered into apoptosis by diverse agents. Resistance to apoptosis could be induced rapidly (within 1 h) by treating with relatively high concentrations of promoters. However, low physiological concentrations of promoters could also induce complete resistance to apoptosis after prolonged exposure (5-15 days of culture). Like tumor promotion in vivo, promoter-induced resistance to apoptosis was reversible after culturing in the absence of promoter. These findings provide new insight into the mechanism of tumor promotion and suggest a novel in vitro screening assay to detect new tumor-promoting agents in the environment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005393     DOI: 10.1096/fasebj.8.9.8005393

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  24 in total

1.  Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis.

Authors:  T H Holmström; S E Tran; V L Johnson; N G Ahn; S C Chow; J E Eriksson
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Grape seed proanthocyanidins induce apoptosis through p53, Bax, and caspase 3 pathways.

Authors:  Anshu M Roy; Manjeshwar S Baliga; Craig A Elmets; Santosh K Katiyar
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

3.  Growth inhibition and apoptosis-induced effect on human cancer cells of toosendanin, a triterpenoid derivative from chinese traditional medicine.

Authors:  Bin Zhang; Zhong-Feng Wang; Mian-Zhi Tang; Yu-Liang Shi
Journal:  Invest New Drugs       Date:  2005-12       Impact factor: 3.850

4.  Apoptosis induced by nucleosides in the human hepatoma HepG2.

Authors:  Suh-Ching Yang; Che-Lin Chiu; Chi-Chang Huang; Jiun-Rong Chen
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

5.  Pro-apoptotic activity of imidazole derivatives mediated by up-regulation of Bax and activation of CAD in Ehrlich Ascites Tumor cells.

Authors:  C Anil Kumar; Shankar Jayarama; Bharathi P Salimath; Kanchugarakoppal S Rangappa
Journal:  Invest New Drugs       Date:  2007-03-20       Impact factor: 3.850

6.  Enterobacter Strains Might Promote Colon Cancer.

Authors:  Dilşad Yurdakul; Ayten Yazgan-Karataş; Fikrettin Şahin
Journal:  Curr Microbiol       Date:  2015-07-05       Impact factor: 2.188

Review 7.  Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industry.

Authors:  Lisa Cosgrove; Ling Shi; David E Creasey; Maria Anaya-McKivergan; Jessica A Myers; Krista F Huybrechts
Journal:  PLoS One       Date:  2011-04-06       Impact factor: 3.240

8.  Osteopontin silencing by small interfering RNA induces apoptosis and suppresses invasion in human renal carcinoma Caki-1 cells.

Authors:  Aimin Zhang; Yi Liu; Yizheng Shen; Youhe Xu; Xiangtie Li
Journal:  Med Oncol       Date:  2009-11-17       Impact factor: 3.064

9.  Thiamethoxam induced hepatotoxicity and pro-carcinogenicity in rabbits via motivation of oxidative stress, inflammation, and anti-apoptotic pathway.

Authors:  Osama S El Okle; Omnia I El Euony; Asmaa F Khafaga; Mohamed A Lebda
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-01       Impact factor: 4.223

Review 10.  Shaping functional gut microbiota using dietary bioactives to reduce colon cancer risk.

Authors:  Derek V Seidel; M Andrea Azcárate-Peril; Robert S Chapkin; Nancy D Turner
Journal:  Semin Cancer Biol       Date:  2017-07-01       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.